Inmune Bio Inc. Faces Crucial Q1 Earnings Report Amid Market Volatility and Biotech Challenges
Inmune Bio Inc. is set to release its Q1 2025 earnings, a critical moment for the biotech company as investors and stakeholders await signs of progress in its pipeline and potential for market success.
2 minutes to read